Press Releases

Active Biotech AB Interim report January-June 2009
August 6, 2009 08:30 (CEST)
Active Biotech's Cancer Project ANYARA Featured in Journal of Clinical Oncology
July 28, 2009 08:30 (CEST)
Number of shares and votes in Active Biotech
June 30, 2009 08:30 (CEST)
Teva Completes Enrollment in Second Oral Laquinimod Phase III MS Clinical Trial
June 25, 2009 14:00 (CEST)
Active Biotech's rights issue substantially oversubscribed
June 15, 2009 08:30 (CEST)
Active Biotech Presents Data regarding the 57-57 SLE Project at EULAR
June 11, 2009 08:30 (CEST)
Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study
June 8, 2009 08:30 (CEST)
Active Biotech Completes Patient Enrollment to ANYARA Phase III Clinical Trial
June 1, 2009 08:30 (CEST)
Announcement of prospectus regarding rights issue in Active Biotech AB (publ)
May 18, 2009 08:30 (CEST)
Annual General Meeting of Active Biotech AB
May 8, 2009 08:30 (CEST)